Shiao Ping Lu
About Shiao Ping Lu
Shiao Ping Lu is the Director of Biostatistics at Adaptimmune, where he has worked since 2020. He has extensive experience in biostatistics, having held various leadership roles in multiple pharmaceutical companies and contributed to significant drug approvals.
Current Role at Adaptimmune
Shiao Ping Lu serves as the Director of Biostatistics at Adaptimmune, a position held since 2020. Based in Philadelphia, PA, Lu oversees biostatistical strategies and methodologies that support clinical trials and regulatory submissions. This role involves collaboration with cross-functional teams to ensure the integrity and accuracy of data analysis throughout the drug development process.
Previous Experience in Biostatistics
Prior to joining Adaptimmune, Shiao Ping Lu held several significant positions in the biostatistics field. Lu worked as the Executive Director of Biostatistics at DURECT Corporation from 2015 to 2016. Lu also served as Sr. Director of Biostatistics at OXiGENE, Inc. from 2009 to 2011, and as Director of Biostatistics at Portola Pharmaceuticals from 2016 to 2018. These roles involved leading statistical teams and contributing to various clinical development projects.
Educational Background
Shiao Ping Lu completed a Bachelor of Science degree at National Taiwan University. Lu furthered education by obtaining multiple Master of Science degrees from the University of Southern California and the University of Massachusetts Amherst. This strong academic foundation supports Lu's expertise in biostatistics and clinical operations.
Contributions to Clinical Trials
Throughout the career, Shiao Ping Lu has contributed to numerous clinical trials and regulatory submissions. Lu played a key role in IND submissions for Phase II trials across various indications, including solid tumors, Alzheimer's Disease, Crohn's disease, and Osteoarthritis. Additionally, Lu was instrumental in the successful NDA submission of Bevyxxa, which received FDA approval in 2017 through a priority review process.
Regulatory Expertise and Business Development
Shiao Ping Lu has represented organizations as a statistical expert at regulatory meetings, addressing reviewers' inquiries to facilitate drug approvals. Lu has also been involved in business development meetings at OXiGENE, Avidia, and Rinat Neuroscience, contributing to due diligence and presentations of study results. This experience underscores Lu's role in bridging statistical analysis with strategic business objectives.